149 related articles for article (PubMed ID: 3082958)
1. Echocardiographic abnormalities and disease severity in Fabry's disease.
Goldman ME; Cantor R; Schwartz MF; Baker M; Desnick RJ
J Am Coll Cardiol; 1986 May; 7(5):1157-61. PubMed ID: 3082958
[TBL] [Abstract][Full Text] [Related]
2. The M-mode echocardiogram in Fabry's disease.
Bass JL; Shrivastava S; Grabowski GA; Desnick RJ; Moller JH
Am Heart J; 1980 Dec; 100(6 Pt 1):807-12. PubMed ID: 6778185
[TBL] [Abstract][Full Text] [Related]
3. New insights in cardiac structural changes in patients with Fabry's disease.
Linhart A; Palecek T; Bultas J; Ferguson JJ; Hrudová J; Karetová D; Zeman J; Ledvinová J; Poupetová H; Elleder M; Aschermann M
Am Heart J; 2000 Jun; 139(6):1101-8. PubMed ID: 10827394
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
[TBL] [Abstract][Full Text] [Related]
5. Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry's disease.
Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Murao K; Kohno M; Itoh S
Tohoku J Exp Med; 2009 Mar; 217(3):169-74. PubMed ID: 19282651
[TBL] [Abstract][Full Text] [Related]
6. [Echocardiographic findings in a case of Fabry's disease with aortic regurgitation and complete AV block, and in his family members].
Iwase M; Yamauchi K; Maeda M; Aoki T; Yokota M; Hayashi H; Sotobata I
J Cardiol; 1988 Jun; 18(2):589-98. PubMed ID: 3150446
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
Spinelli L; Pisani A; Sabbatini M; Petretta M; Andreucci MV; Procaccini D; Lo Surdo N; Federico S; Cianciaruso B
Clin Genet; 2004 Aug; 66(2):158-65. PubMed ID: 15253767
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary involvement in Fabry's disease.
Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular manifestations in Fabry's disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes.
Sakuraba H; Yanagawa Y; Igarashi T; Suzuki Y; Suzuki T; Watanabe K; Ieki K; Shimoda K; Yamanaka T
Clin Genet; 1986 Apr; 29(4):276-83. PubMed ID: 3087663
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
Mignani R; Cagnoli L
J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
[TBL] [Abstract][Full Text] [Related]
11. Fabry's disease--a case report and review of literatures reported in Korea.
Lee SY; Kim SJ; Lee JI; Kim ES; Lee CH; Kim JH; Jeong HJ; Ha SK
Yonsei Med J; 1998 Feb; 39(1):67-72. PubMed ID: 9529988
[TBL] [Abstract][Full Text] [Related]
12. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
[TBL] [Abstract][Full Text] [Related]
13. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization.
Pieroni M; Chimenti C; De Cobelli F; Morgante E; Del Maschio A; Gaudio C; Russo MA; Frustaci A
J Am Coll Cardiol; 2006 Apr; 47(8):1663-71. PubMed ID: 16631007
[TBL] [Abstract][Full Text] [Related]
14. Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry's disease.
Kawano M; Takenaka T; Otsuji Y; Teraguchi H; Yoshifuku S; Yuasa T; Yu B; Miyata M; Hamasaki S; Minagoe S; Kanmura Y; Tei C
Am J Cardiol; 2007 Jan; 99(2):261-3. PubMed ID: 17223430
[TBL] [Abstract][Full Text] [Related]
15. High incidence of thrombosis in Fabry's disease.
Utsumi K; Yamamoto N; Kase R; Takata T; Okumiya T; Saito H; Suzuki T; Uyama E; Sakuraba H
Intern Med; 1997 May; 36(5):327-9. PubMed ID: 9213168
[TBL] [Abstract][Full Text] [Related]
16. [Cardiac manifestations of Fabry's disease].
Han ZH; Jiang TY; Ren XJ; Wu XS; Zhang WD; Chen F
Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):462-4. PubMed ID: 19954039
[TBL] [Abstract][Full Text] [Related]
17. Fabry's disease.
Adam T; Alexandrescu L; Voinea F; Toringhibel M; Hâncu A
Rom J Intern Med; 2006; 44(4):455-64. PubMed ID: 18386622
[TBL] [Abstract][Full Text] [Related]
18. [Cardiac manifestations in Fabry disease].
Lappegård KT; Aass H
Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2395-6. PubMed ID: 11475223
[TBL] [Abstract][Full Text] [Related]
19. [Ocular findings in Fabry's disease].
Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
[TBL] [Abstract][Full Text] [Related]
20. First-degree atrioventricular block and restrictive physiology as cardiac manifestations of Fabry's disease.
Blum A; Ashkenazi H; Haromankov I; Khazim K; Sheiman J
South Med J; 2003 Feb; 96(2):212-3. PubMed ID: 12630653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
